{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:32:34Z","timestamp":1717785154477},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T00:00:00Z","timestamp":1222992000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cholesterol embolization or atheroembolic renal disease (AERD) is an often underdiagnosed issue in patients featuring a prevalent risk profile. It is a multisystemic disease with progressive renal insufficiency due to foreign body reaction of cholesterol crystals flushed into a small vessel system of the kidneys from the arteriosclerotic plaques. The most common setting in which it occurs is iatrogenic after vascular catheterization and less frequent spontaneously. Typical clinical symptoms are delayed impairment of renal function, cutaneous manifestations such as <jats:italic>livedo reticularis<\/jats:italic> or purple toes with persistingly palpable arterial pulse, myalgia, systemic symptoms such as weight loss and fever, and abdominal and neurological symptoms. Diagnosis is generally made by clinical appearance, risk profile, and interval of time from intervention; a definitive diagnosis can only be made by renal biopsy. Even though the exact incidence is not known because most patients do not undergo biopsy due to older age, comorbidity, and other explanations for loss of renal function, it is estimated to be 4% after vascular intervention. Patient and renal outcome is dependent on comorbidity, risk profile, and preexisting chronic kidney disease (CKD). About 30% of patients are estimated to require maintenance dialysis and these patients have a high risk of death within 24 months after the first renal replacement therapy. Prognosis is also influenced by severity. The case reported is a 72\u2010year\u2010old male patient with preexisting CKD stage 3 undergoing percutaneous coronary intervention after myocardial infarction and consecutive AERD with typical clinical appearance 6 weeks after the event.<\/jats:p>","DOI":"10.1111\/j.1542-4758.2008.00303.x","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T09:40:00Z","timestamp":1223026800000},"page":"406-411","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Atheroembolic renal disease in a 72\u2010year\u2010old patient through coronary intervention after myocardial infarction"],"prefix":"10.1111","volume":"12","author":[{"given":"Anna Laura","family":"HERZOG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"WANNER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,3]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"769","article-title":"Cholesterol crystal embolization","volume":"38","author":"Fine MJ","year":"1987","journal-title":"A review of 221 cases in English literature"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.5.1259"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200005270-00050"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1681\/ASN.V62165","article-title":"Cholesterol emboli presenting as acute allograft dysfunction after renal transplantation","volume":"6","author":"Singh I","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_6_2","first-page":"261","article-title":"Artheromatous emboli in renal biopsies","volume":"78","author":"Jones DB","year":"1975","journal-title":"Am J Pathol"},{"key":"e_1_2_5_7_2","first-page":"669","article-title":"Renal biopsy in patients 65 years of age and older","volume":"28","author":"Preston RA","year":"1990","journal-title":"An analysis of the results of 334 biopsies"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.7.860"},{"key":"e_1_2_5_9_2","first-page":"1471","article-title":"Cholesterol crystal embolization to the digestive system","volume":"98","author":"Ben\u2010Horin S","year":"2003","journal-title":"Characterization of a common, yet overlooked presentation of atheroembolism"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02018173"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1986.01660220112024"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.30.4.611"},{"key":"e_1_2_5_13_2","first-page":"433","article-title":"Etiologies and outcome of acute renal insufficiency in older adults","volume":"35","author":"Haas M","year":"2000","journal-title":"A renal biopsy study of 259 cases"},{"key":"e_1_2_5_14_2","first-page":"1089","article-title":"Cholesterol crystal embolism","volume":"36","author":"Scolari F","year":"2000","journal-title":"A recognizable cause of renal disease"},{"key":"e_1_2_5_15_2","first-page":"685","article-title":"Angiotensin\u2010converting enzyme inhibitor\u2010associated elevations in serum creatinine","volume":"160","author":"Bakris GL","year":"2000","journal-title":"Is this a cause for concern?"},{"key":"e_1_2_5_16_2","first-page":"240","article-title":"Renal failure and cholesterol crystal embolization","volume":"36","author":"Manesse CK","year":"1991","journal-title":"A report of 4 surviving cases and a review of literature"},{"key":"e_1_2_5_17_2","first-page":"298","article-title":"The challenge of diagnosing artheroembolic renal disease","volume":"116","author":"Scolari F","year":"2007","journal-title":"Clinical features and prognostic factors"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199511000-00005"},{"key":"e_1_2_5_19_2","first-page":"211","article-title":"The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization","volume":"42","author":"Fukumoto Y","year":"2003","journal-title":"A prospective study"},{"key":"e_1_2_5_20_2","first-page":"713","article-title":"Nephrotoxic risks of renal angiography","volume":"24","author":"Rudnick MR","year":"1994","journal-title":"Contrast media associated nephrotoxicity an atheroembolism: A critical review"},{"key":"e_1_2_5_21_2","unstructured":"ModiK RaoKV.Clinical presentation and survival on dialysis of patients with atheroembolic renal disease (AERD) [abstract]. Fifth Asian Pacific Congress of Nephrology 1992 New Delhi India."},{"key":"e_1_2_5_22_2","first-page":"1430","article-title":"Cholesterol embolization","volume":"138","author":"Ramirez G","year":"1978","journal-title":"A complication of angiography"},{"issue":"100","key":"e_1_2_5_23_2","first-page":"8","article-title":"Contrast medium\u2010induced nephropathy","volume":"4","author":"Persson PB","year":"2006","journal-title":"The pathophysiology"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1066"},{"key":"e_1_2_5_25_2","first-page":"2256","article-title":"The role of osmolality in the incidence of contrast\u2010induced nephropathy","volume":"68","author":"Salomon R.","year":"2005","journal-title":"A systematic review of angiographic contrast media in high risk patients"},{"key":"e_1_2_5_26_2","first-page":"368","article-title":"Acute renal failure after coronary intervention","volume":"103","author":"McCullogh PA","journal-title":"Incidence, risk factors, and relationship to mortality"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000016043.87291.33"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.07.043"},{"key":"e_1_2_5_29_2","first-page":"563","article-title":"Acute myocardial infarction and renal dysfunction","volume":"137","author":"Wright RS","year":"2002","journal-title":"A high-risk combination"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-4758.2008.00303.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2008.00303.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T21:03:47Z","timestamp":1696971827000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-4758.2008.00303.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1542-4758.2008.00303.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-4758.2008.00303.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}